The pentose phosphate pathway is a route for breaking down glucose that runs alongside the more famous energy-producing chain of reactions most people learn about in school. Instead of generating energy directly, it produces two things cells constantly need: a molecule called NADPH, which acts as the cell’s main chemical reducing agent, and a five-carbon sugar called ribose-5-phosphate, which is the backbone of DNA and RNA. The pathway matters far beyond textbook metabolism, showing up in immune defense, cancer biology, brain protection, inherited blood disorders, and even theories about the origin of life on Earth.
What the Pathway Actually Does
Every cell that uses glucose has access to the pentose phosphate pathway. It branches off from the very first step of normal glucose processing and channels some of that glucose toward two specialized products. The first, NADPH, is a packet of chemical reducing power that cells spend on building fatty acids, cholesterol, certain amino acids, and the active forms of folate, among other things. The second product, ribose-5-phosphate, feeds directly into the production of nucleotides, the building blocks of DNA and RNA.1PubMed Central. The pentose phosphate pathway in health and disease Any cell that needs to copy its genome or repair damaged DNA needs a supply of ribose-5-phosphate, which makes the pathway especially active in rapidly dividing cells.
The pathway is split into two halves. The first half, called the oxidative branch, is where glucose gets irreversibly converted and NADPH is generated. The second half, the non-oxidative branch, is a flexible set of reactions that can shuffle carbon atoms between sugars of different sizes. Depending on what the cell needs at the moment, this non-oxidative branch can funnel leftover carbons back into mainstream glucose processing, or it can run in reverse to produce more ribose-5-phosphate from other sugar intermediates. That flexibility lets the cell tune the pathway’s output on the fly: more NADPH when under stress, more ribose when dividing, or a mix of both.
The Cell’s Antioxidant Fuel Supply
One of the pathway’s most critical everyday jobs is keeping cells from being destroyed by their own chemistry. Normal metabolism constantly generates reactive oxygen species, aggressive molecules that can damage proteins, fats, and DNA. Cells neutralize these threats with a small molecule called glutathione, which works by donating electrons to neutralize reactive oxygen. After glutathione does its job, it becomes oxidized and temporarily useless. To recycle it back into active form, the cell relies on an enzyme called glutathione reductase, and that enzyme runs on NADPH.2Biology of Reproduction. Functional Significance of the Pentose Phosphate Pathway and Glutathione Reductase in the Antioxidant Defenses of Human Sperm Without a steady supply of NADPH from the pentose phosphate pathway, this recycling stops and reactive oxygen species accumulate unchecked.
This relationship between the pathway and antioxidant defense explains why some cells are more vulnerable than others when the pathway is impaired. Red blood cells, for instance, have no mitochondria and rely almost entirely on the pentose phosphate pathway for their NADPH. If the pathway’s gatekeeper enzyme is underperforming, red blood cells lose the ability to recycle glutathione and become sitting targets for oxidative damage.
G6PD Deficiency and Favism
The gatekeeper enzyme is glucose-6-phosphate dehydrogenase, usually shortened to G6PD. It catalyzes the very first reaction of the oxidative branch, making it the rate-limiting step for NADPH production through this route. Mutations that reduce G6PD activity are the most common inherited enzyme disorder in humans, affecting more than 400 million people worldwide, roughly 90 percent of them male because the gene sits on the X chromosome.3PubMed. Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents
People with G6PD deficiency usually feel perfectly fine under normal conditions. The trouble starts when something sharply increases oxidative stress in red blood cells, whether that is certain drugs, infections, or specific foods. The classic trigger is fava beans, which is why the condition has historically been called favism in Mediterranean populations. When a person with low G6PD activity encounters one of these triggers, their red blood cells cannot produce enough NADPH to keep glutathione recycled. Hydrogen peroxide builds up, damages both the fats and proteins in the cell membrane, and the red blood cells rupture or get flagged for destruction by the immune system. The result is hemolytic anemia that can range from mild to life-threatening.4Free Radical Biology and Medicine. Perspectives on hydrogen peroxide and drug-induced hemolytic anemia in glucose-6-phosphate dehydrogenase deficiency
Certain medications are well-known triggers. Antimalarial drugs like primaquine and antibiotics like dapsone generate metabolites that directly induce oxidative stress in red blood cells, disrupting membrane integrity and leading to their destruction.5PubMed Central. Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights This is why G6PD status is sometimes checked before prescribing these drugs, particularly in populations where deficiency is common.
Why G6PD Deficiency Is So Common
An inherited condition that makes your red blood cells fragile seems like something natural selection would weed out. The reason it persists is the same reason sickle cell trait persists: malaria. Red blood cells with reduced G6PD activity appear to create a less hospitable environment for the malaria parasite Plasmodium falciparum. In regions where malaria has historically been endemic, carrying one copy of a G6PD-deficiency allele confers a survival advantage that outweighs the risk of occasional hemolytic episodes.6PubMed. Glucose 6-phosphate dehydrogenase deficiency: a protection against malaria and a risk for hemolytic accidents
The geographic evidence is striking. Studies of Chinese populations found that the frequency of G6PD-deficient alleles closely tracks regions with a historical prevalence of malaria and correlates negatively with altitude and latitude, exactly what you would expect if malaria had been the selective pressure driving the trait’s spread.7PubMed Central. Epidemiology, evolutionary origin, and malaria‐induced positive selection effects of G6PD‐deficient alleles in Chinese populations This pattern has been replicated across sub-Saharan Africa, the Mediterranean, and Southeast Asia, making G6PD deficiency one of the clearest examples of balanced selection in human genetics.
Cancer Cells and Their Appetite for the Pathway
Cancer cells face two metabolic problems simultaneously: they need raw materials to build new cells at a furious rate, and they produce enormous amounts of reactive oxygen species as a byproduct of their altered metabolism. The pentose phosphate pathway helps solve both problems at once, supplying ribose-5-phosphate for nucleotide production and NADPH for both biosynthesis and antioxidant defense. It is no surprise, then, that many cancers evolve to push more glucose through this pathway than normal cells do.8PubMed Central. The pentose phosphate pathway and cancer
The upregulation of the pathway in cancer is closely tied to the Warburg effect, the long-observed tendency of tumor cells to consume glucose at high rates even when oxygen is plentiful.9PubMed Central. The return of metabolism: biochemistry and physiology of the pentose phosphate pathway Flooding the cell with glucose intermediates means more substrate is available to divert into the pentose phosphate pathway. Research into gastrointestinal cancers has highlighted how the pathway modulates the tumor microenvironment by balancing redox chemistry and feeding nucleotide production.10PubMed Central. The Pentose Phosphate Pathway: From Mechanisms to Implications for Gastrointestinal Cancers
Research has also revealed that the story is more complicated than just one enzyme being turned up. Cancer cells appear to use not only the classic G6PD enzyme but also a related enzyme called H6PD that operates inside a different cellular compartment, the endoplasmic reticulum. When researchers silenced either G6PD or H6PD individually in breast and lung cancer cell lines, both caused a similar drop in pathway intermediates and NADPH, followed by rising reactive oxygen levels and slower growth.11Scientific Reports. Two high-rate pentose-phosphate pathways in cancer cells This means cancer cells effectively run two parallel versions of the pathway, giving them a redundancy that could make single-target therapies less effective.
Targeting G6PD as a Cancer Strategy
Because the pentose phosphate pathway is so important to tumor survival, blocking it has become a target of interest in cancer drug research. The idea is straightforward: if you inhibit G6PD, cancer cells lose their NADPH supply, reactive oxygen species overwhelm their defenses, and the cells die or stop dividing. In laboratory studies, the natural compound polydatin has been shown to inhibit G6PD, causing a buildup of reactive oxygen species and severe stress in the endoplasmic reticulum of cancer cells, which suppressed both proliferation and metastasis.12Cell Death & Disease. A new inhibitor of glucose-6-phosphate dehydrogenase blocks pentose phosphate pathway and suppresses malignant proliferation and metastasis in vivo
Computational drug-screening efforts have also identified additional candidate molecules that bind G6PD’s active site and meet basic criteria for drug-like properties.13PubMed. Identification of Glucose-6-Phosphate Dehydrogenase (G6PD) Inhibitors by Cheminformatics Approach None of these compounds have reached clinical use yet. The challenge is selectivity: G6PD is also essential in healthy cells, particularly red blood cells, immune cells, and the brain. A drug that blocks it too broadly could mimic the symptoms of G6PD deficiency. Getting the dose and tissue targeting right remains an open problem, but the pathway’s outsize role in cancer metabolism keeps attracting attention.
Immune Cells Weaponize the Pathway
Immune cells use the pentose phosphate pathway in a way that flips the antioxidant story on its head. White blood cells like neutrophils and macrophages deliberately produce massive bursts of reactive oxygen species to kill bacteria and other pathogens. The enzyme responsible, called NOX2, needs NADPH as its fuel. So when these cells activate in response to infection, they ramp up the pentose phosphate pathway to supply the NADPH that powers their oxidative burst.
Experiments with macrophages have shown that blocking the pentose phosphate pathway with an inhibitor called 6-aminonicotinamide suppresses the activity of NOX2 and reduces the expression of genes associated with the oxidative burst triggered by bacterial molecules.14PubMed Central. Glycolysis and the Pentose Phosphate Pathway Promote LPS-Induced NOX2 Oxidase- and IFN-β-Dependent Inflammation in Macrophages In neutrophils, researchers found that the balance between normal glucose processing and the pentose phosphate pathway acts as a switch. An enzyme called PFKL, which promotes the standard glycolysis pathway, acts as a negative regulator of the oxidative burst. When PFKL activity drops, more glucose gets shunted into the pentose phosphate pathway, NADPH production rises, and the neutrophil’s killing power increases. Activating PFKL does the opposite, dialing down the burst by starving NOX2 of its NADPH fuel.15Cell. Small-molecule activation of PFKL suppresses neutrophil activation and tissue damage
This finding has clinical implications. Excessive neutrophil activation contributes to tissue damage in conditions like sepsis, acute lung injury, and autoimmune flares. If you could pharmacologically tip the glucose-processing balance away from the pentose phosphate pathway in overactive immune cells, you might reduce collateral tissue damage without completely disabling pathogen defense. That is exactly the principle behind the PFKL-activating compound described in the research, which suppressed harmful neutrophil-driven inflammation in experimental models.
The Pathway in the Brain
Brain cells have a particularly interesting relationship with the pentose phosphate pathway. Neurons are metabolically voracious and extremely sensitive to oxidative damage, but much of their antioxidant protection appears to come not from the neurons themselves but from neighboring support cells called astroglia. When researchers exposed cultured brain cells to high glucose, astroglia ramped up their pentose phosphate pathway activity, boosted their glutathione levels, and reduced reactive oxygen species production. Neurons, by contrast, showed much less pathway activity under the same conditions.16PubMed Central. Astroglial pentose phosphate pathway rates in response to high-glucose environments
This division of labor suggests that astroglia act as a metabolic shield for the neurons around them, absorbing oxidative stress by cycling glucose through the pentose phosphate pathway and sharing the resulting antioxidant capacity. It also raises questions about what happens in diseases where astroglial function is compromised, such as certain neurodegenerative conditions, and whether supporting the pathway in those cells could protect vulnerable neurons.
How the Pathway Regulates Itself
The cell needs a way to crank up NADPH production when demand spikes, such as during a sudden burst of oxidative stress. For decades, the dominant explanation was a simple feedback loop: as the cell uses up NADPH and oxidized NADP+ accumulates, the shift in concentration activates G6PD and the pathway speeds up. Early biochemical work on red blood cells showed that both NADP+ and NADPH bind G6PD at concentrations close to what actually exists inside the cell, suggesting that normal fluctuations in these molecules could plausibly regulate the enzyme.17Biochimica et Biophysica Acta (BBA) – Enzymology. Regulation of the activity of glucose-6-phosphate dehydrogenase by NADP+ and NADPH
However, recent computational modeling has challenged the idea that this feedback loop is sufficient on its own. When researchers simulated what would happen to NADPH levels during a sudden pulse of hydrogen peroxide, they found that maintaining a stable NADPH concentration through feedback inhibition alone would require an enzyme sensitivity far beyond what is biologically realistic.18bioRxiv. The activation of pentose phosphate pathway flux by hydrogen peroxide is not regulated by NADPH-mediated feedback inhibition The model predicted that additional mechanisms, perhaps involving direct activation of the enzyme by hydrogen peroxide or other redox signals, must be at play. The full regulatory picture remains an active area of research, which is a reminder that even a pathway discovered decades ago can still hold surprises.
Plants and Photosynthesis
The pentose phosphate pathway is not exclusive to animals. Plants run the pathway in multiple compartments of their cells, and it intersects in interesting ways with photosynthesis. The non-oxidative branch of the pathway shares several reactions with the Calvin-Benson cycle, the set of reactions that plants use to fix carbon dioxide into sugar during photosynthesis. In fact, some of the same enzymes participate in both processes.
Research on photosynthesizing cells has found that a shunt running through the non-oxidative pentose phosphate pathway can operate constitutively in the cytosol, producing an unusual labeling pattern in photosynthetic metabolites that would not be expected if the Calvin-Benson cycle were the only game in town. Under stress, a second version of this shunt appears to activate in the chloroplast itself.19PubMed Central. Pentose Phosphate Pathway Reactions in Photosynthesizing Cells In oilseed crops like rapeseed, the oxidative branch has been shown to ramp up dramatically during fatty acid synthesis in developing embryos, because making fat requires large quantities of NADPH.20Journal of Experimental Botany. Fatty acid synthesis and the oxidative pentose phosphate pathway in developing embryos of oilseed rape (Brassica napus L.) The pathway’s flexibility in plants is part of what makes it central to agricultural traits like oil content in seeds.
A Pathway Older Than Life Itself
Perhaps the most surprising thing about the pentose phosphate pathway is that its core chemistry may predate living cells entirely. Researchers reconstituted conditions thought to mimic the early Archean ocean, with iron-rich water and no enzymes present, and found that the resulting chemistry spontaneously produced many of the same interconversions that make up both glycolysis and the pentose phosphate pathway. The non-enzymatic reactions generated glucose, pyruvate, ribose-5-phosphate, and erythrose-4-phosphate, key metabolic intermediates that modern cells produce using enzymes.21PubMed Central. Non-enzymatic glycolysis and pentose phosphate pathway-like reactions in a plausible Archean ocean
Follow-up work showed that the pH of the environment acted as a switch: alkaline conditions favored the pentose phosphate pathway reactions, while slightly acidic or neutral conditions favored glycolysis-like chemistry.22PubMed Central. Conditional iron and pH-dependent activity of a non-enzymatic glycolysis and pentose phosphate pathway Even the phosphorylation step that normally requires enzymes could be achieved under prebiotic conditions using borate minerals and thermal evaporation, producing glucose-6-phosphate and other phosphorylated intermediates in the absence of any biological catalyst.23PubMed Central. Hexose phosphorylation for a non-enzymatic glycolysis and pentose phosphate pathway on early Earth
These findings have reshaped thinking about how metabolism originated. Rather than enzymes inventing metabolic pathways from scratch, the chemistry may have come first, constrained by the mineral environment of early Earth. Enzymes then evolved to speed up and control reactions that were already happening spontaneously. If that view is correct, the pentose phosphate pathway is not just a useful piece of cellular machinery. It is one of the oldest chemical networks on the planet, a relic of geochemistry that biology inherited and refined over billions of years.
Carbon Monoxide Signaling and Blood Vessels
A less obvious place the pathway shows up is in blood vessel biology. Endothelial cells, the thin layer of cells lining every blood vessel, produce nitric oxide to relax surrounding smooth muscle and regulate blood pressure. Generating nitric oxide requires NADPH, linking vascular tone directly to pentose phosphate pathway activity. Researchers studying carbon monoxide-releasing molecules (compounds being explored as experimental vasodilators) found that one such compound, CORM-401, accelerated the pentose phosphate pathway in endothelial cells, raised NADPH concentration, and boosted nitric oxide production. When they blocked the pathway with an inhibitor, the nitric oxide increase was suppressed.24PubMed. CORM-401 induces calcium signalling, NO increase and activation of pentose phosphate pathway in endothelial cells The finding illustrates how the pathway sits at unexpected metabolic intersections, linking glucose metabolism to vascular function through the shared currency of NADPH.